摘要:
The present inventions relate to a base comprising amorphous agar for a sustained-release pharmaceutical preparation, a production method of the sustained-release pharmaceutical preparation which method using the amorphous agar as the base, and a sustained-release pharmaceutical preparation in which the amorphous agar is combined as the base. According to the present inventions, the sustained-release pharmaceutical preparation is provided by using a conventional method.
摘要:
A hair growth promoting aerosol formulation having a hair growth promoter composition in a gel form containing as effective components a crude drug extract having an effect of promoting the circulation of blood and a vitamin or a derivative thereof, and a water-soluble polymer by which the hair growth promoter composition is gelatinized; and a propellant. There is also disclosed an aerosol product of a hair growth promoter prepared by filling the above-mentioned hair growth promoting aerosol formulation in an aerosol container provided with a nozzle having a diameter of 1 mm or less.
摘要:
Specified cinnamic acid derivatives, such as methyl 4-(4-acetoxy-3-methoxycinnamamide)-1-methyl-1-cyclohexanecarboxylate, and pharmaceutically acceptable salts thereof, which are useful as an allergy type IV reaction inhibitor.
摘要:
Polycyclic compounds (I) can be prepared in accordance with the following reaction formula:
wherein R₁-R₈ each represents a hydrogen atom, a hydroxyl group, an alkoxyl group or a substituted or unsubstituted benzyloxy group or neighboring two groups of R₁-R₈ are coupled together to form an alkylenedioxy group; and A is an alkylene group which may be substituted by one or more alkoxycarbonyl groups, an alkenylene group which may be substituted by one or more alkoxycarbonyl groups, or a group represented by any one of the following formulas:
摘要:
An alleviant for the side effects caused by drugs, containing as the active ingredient at least one compound selected from the group consisting of malic, aspartic, tartaric, malonic, succinic, oxalic and tridecanoic acids as well as pharmaceutically acceptable salts thereof. It can alleviate side effects, in particular, nephrotoxicity, hemotoxicity, etc., caused by the administration of platinum complexes such as cisplatin.
摘要:
An alleviant for the side effects caused by drugs, containing as the active ingredient at least one compound selected from the group consisting of malic, aspartic, tartaric, malonic, succinic, oxalic and tridecanoic acids as well as pharmaceutically acceptable salts thereof. It can alleviate side effects, in particular, nephrotoxicity, hemotoxicity, etc., caused by the administration of platinum complexes such as cisplatin.
摘要:
A keratosis-treating agent is disclosed, which contains as an effective ingredient at least one compound selected from among trans-(6)-shogaol and cis-(6)-shogaol. Of the above-described compounds, cis-(6)-shogaol is a novel compound.
摘要:
A composition for the rectal administration of difficultly absorbable peptides, comprising a difficultly absorbable peptide as the active ingredient, a C8 to C14 saturated fatty acid or an avirulent salt thereof, and a protease inhibitor. The composition allows peptides which have been believed to be difficult to absorb to be absorbed efficiently through the rectal mucosa, so that it can achieve an excellent pharmacological efficacy without resort to injection which is painful and is limited in its administration. Further it has an economic advantage because it can provide a pharmaceutical preparation of relatively expensive peptides witha reduced loss thereof.
摘要:
An antiretroviral agent containing as the active ingredient a compound of general formula (I) or a pharmaceutically acceptable salt thereof, wherein R₁ and R₂ may be the same or different from each other and each represents hydrogen, sodium or potassium.